Oncopeptides Competitors and Similar CompaniesClear all

Oncopeptides's competitors and similar companies include CureVac, PLIVA, Biocon and Ethypharm.

	Oncopeptides Oncopeptides is a clinical development pharmaceutical company.	CureVac CureVac is a biotechnology company offering messenger RNA (mRNA) technology.	PLIVA PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products.	Biocon Biocon is a global biopharmaceutical company.	Ethypharm Ethypharm is a specialty pharmaceutical company focused on the treatment of pain and addiction.
Founding Date	Founding Date 2000	Founding Date 2000	Founding Date 1921	Founding Date 1978	Founding Date 1977
Type	Type Public	Type Public	Type Subsidiary	Type Public	Type Private
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Stockholm, SE HQ Stockholm, SE Los Altos, US Mountain View, US Waltham, US	Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US	Locations Zagreb, HR HQ Sarajevo, BA Skopje, MK Belgrade, RS	Locations Bengaluru, IN HQ Bengaluru, IN Hyderabad, IN Visakhapatnam, IN Dublin, IE Kuala Lumpur, MY Puchong, MY see more	Locations Saint-Cloud, FR HQ Montréal, CA Châteauneuf En Thymerais, FR Nyons, FR Saint Cloud, FR see more
Employees	Employees 678% increase	Employees 999	Employees 1,655	Employees 16,315	Employees 1,002
Valuation ($)	Valuation ($) 43.2 m	Valuation ($) 652.8 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) kr35.2m (FY, 2023)	Revenue (est.) €53.8m (FY, 2023)	Revenue (est.) N/A	Revenue (est.) ₹142b (FY, 2024)	Revenue (est.) N/A
Cost of goods	Cost of goods (kr1.1m) (FY, 2023)	Cost of goods €64.3m (FY, 2023)	Cost of goods N/A	Cost of goods ₹50.9b (FY, 2024)	Cost of goods N/A
Gross profit	Gross profit kr42.6m (FY, 2023)	Gross profit (€2.6m) (FY, 2023)	Gross profit N/A	Gross profit ₹102b (FY, 2024)	Gross profit N/A
Net income	Net income (kr249.1m) (FY, 2023)	Net income (€260.2m) (FY, 2023)	Net income N/A	Net income ₹13b (FY, 2024)	Net income N/A